COPD readmission risk review
Evidence synthesis - owner Clinical analytics - due May 18, 2026
Clinical operations, evidence workflows, reporting, and platform health.
Portfolio
Evidence synthesis - owner Clinical analytics - due May 18, 2026
Protocol mapping - owner Research operations - due May 24, 2026
Report drafting - owner Quality team - due May 14, 2026
Data inventory - owner Registry program - due June 3, 2026